U.S. market Closed. Opens in 11 hours 32 minutes

MNPR | Monopar Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses8.83M10.54M9.13M6.51M4.32M3.40M16.60MN/A
Selling, General & Admin3.23M2.95M2.63M2.44M2.36M1.63M1.17M912.47K
Research & Development5.60M7.59M6.49M4.07M1.97M1.77M15.44M280.36K
Other Operating ExpensesN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-8.83M-10.54M-9.13M-6.51M-4.32M-3.40M-16.60M-1.19M
Other Expenses / Income429.04K21.24K24.02K204.30K98.89K103.22K48.26K7.23K
Before Tax Income-8.40M-10.52M-9.10M-6.30M-4.22M-3.30M-16.55M-1.19M
Income Tax Expenses-8.83K-21.24K-24.02K-81.90K-98.89K-71.61KN/AN/A
Net Income-8.40M-10.49M-9.08M-6.22M-4.13M-3.23M-16.55M-1.19M
Interest ExpensesN/A-21.24KN/AN/AN/A103.22K48.26KN/A
Basic Shares Outstanding2.76M12.72M12.47M10.96M10.59M10.42M10.42M10.42M
Diluted Shares Outstanding2.76M12.72M12.47M10.96M10.59M10.42M10.42M10.42M
EBITDA-8.83M-10.54M-9.13M-6.63M-4.32M-3.40M-16.51M-1.19M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-8.41M-10.54M-9.10M-6.30M-4.22M-3.20M-16.51M-1.19M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙